The latest price target for Bruker (NASDAQ:BRKR) was reported by UBS on May 7, 2026. The analyst firm set a price target for $45.00 expecting BRKR to rise to within 12 months (a possible 5.26% upside). 34 analyst firms have reported ratings in the last year.

The latest analyst rating for Bruker (NASDAQ:BRKR) was provided by UBS, and Bruker maintained their neutral rating.

The last upgrade for Bruker Corp happened on December 10, 2025 when Wolfe Research raised their price target to $60. Wolfe Research previously had a peer perform for Bruker Corp.

The last downgrade for Bruker Corp happened on May 22, 2025 when Citigroup changed their price target from $50 to $40 for Bruker Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on May 7, 2026 so you should expect the next rating to be made available sometime around May 7, 2027.

While ratings are subjective and will change, the latest Bruker (BRKR) rating was a maintained with a price target of $40.00 to $45.00. The current price Bruker (BRKR) is trading at is $42.75, which is within the analyst’s predicted range.